Advertisement
News
Advertisement

ResMed Launches Narval™ CC Mandibular Repositioning Device in the US

Wed, 06/13/2012 - 1:32pm
Bio-Medicine.Org

SAN DIEGO, June 13, 2012 /PRNewswire/ -- ResMed Inc. (NYSE: RMD), a leading developer, manufacturer and distributor of sleep and respiratory medical equipment, announced the US launch of Narval™ CC, its state-of-the-art mandibular repositioning device. The company unveiled the product at last week's American Academy of Dental Sleep Medicine annual meeting. Building on years of market leadership in France, its country of origin, Narval CC is an innovative, effective, world-class device that offers an alternative solution to patients for snoring and obstructive sleep apnea.

(Photo: http://photos.prnewswire.com/prnh/20120613/LA24222)

(Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

ResMed's introduction of Narval CC follows its acquisition of the France-based Labaratoires Narval. With the acquisition, ResMed added an additional therapy method to complement its comprehensive positive airway pressure (PAP) solutions, providing a broader offering for snoring and obstructive sleep apnea sufferers.

"Obstructive sleep apnea is a severe disease which, left untreated, can have significant long-term impacts on serious conditions including heart disease, type 2 diabetes, obesity, chronic obstructive pulmonary disease, and, as very recent research has shown, cancer," stated Michael Farrell, president, ResMed Americas.  "The gold-standard therapy for obstructive sleep apnea is PAP therapy.  However, we know that today some patients either refuse PAP treatment or fail to comply. Narval CC provides an effective alternative for those untreated patients. With the release of Narval CC, ResMed is now the only PAP company with a customized solution for noncompliant patients or patients who refuse PAP treatment, giving

'/>"/>

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading